Long-Term Follow-Up for KYV-101 Treatment
A Long-Term Follow-Up Study for Participants Previously Treated With KYV-101
Recruiting
Observational Study
Refractory Lupus Nephritis
Myasthaenia Gravis
Stiff Person Syndrome
Rheumatoid Arthritis (RA)
Multiple Sclerosis
Dermatomyositis
Systemic Sclerosis (SSc)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 70 (estimated)
- Sponsor
- Kyverna Therapeutics · Industry
Who this trial is looking for
This trial is looking for people who have previously received KYV-101 treatment. Participants will help researchers understand the long-term effects of this treatment.
Are You a Good Fit for This Trial?
You may be able to join if
- I have provided consent to take part in this follow-up study.
- I received at least one infusion of KYV-101 in a previous trial.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your Eligibility
About This Trial
The purpose of this long-term follow-up (LTFU) study is to collect delayed adverse events (AEs) and understand the persistence of KYV-101 (autologous CAR T cell product; gene-modified product), in participants who have been administered KYV-101 (gene-modified product; autologous CAR T cell product).
This LTFU protocol will be open to any participant who received at least one infusion of KYV-101 i…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Provided informed consent for the LTFU study
* Received at least 1 infusion of KYV-101 as part of a previous KYV-101 parent treatment protocol
Exclusion Criteria:
* Not applicable
Contacts